Strongbridge CareConnection Patient Support

Strongbridge CareConnection makes sure patients are getting the support they need

Strongbridge CareConnection Patient Support
Eligible patients pay as little as $0

Strongbridge is committed to providing a wide range of services and support for patients and their family members living with Adult Growth Hormone Deficiency. Call 844‑MAC‑AGHD (622‑2443) or visit www.macrilen.com/careconnection for more information on any of the support services listed below.

Product coverage

  • Patient benefit verification and coverage information
  • Prior authorization and appeal resources

Patient access and affordability

  • Co-pay savings program
  • Patient assistance program

Reimbursement

  • Coding recommendations and information
  • Resources for denials and appeals

Product distribution

  • Information on authorized distributors
  • Coordinating specialty pharmacy ordering and fulfillment

*With an annual co-pay assistance of $1,000. Coverage is limited to co-pay or co-insurance for Macrilen product only and does not include deductible amounts or other office visits, procedures or administration costs. Additional terms and conditions may apply. For the full terms and conditions please call 844‑MAC‑AGHD (622‑2443).


Important Safety Information for Macrilen

What is Macrilen?

Macrilen (pronounced ma-kri-len) (macimorelin) is a prescription oral solution that is used to test for adult growth hormone deficiency (AGHD).

What should you know about Macrilen?

  • Taking Macrilen with certain other medications may cause irregular changes to your heart rhythm. Before taking Macrilen, tell your healthcare provider about all your medications, as you may need to temporarily stop taking some medications before you take Macrilen.
  • Some medications may cause a false positive result when taken with Macrilen. Before taking Macrilen, tell your healthcare provider about all the medications you take, including growth hormone.
  • Tell your healthcare provider if you were recently diagnosed with hypothalamic disease, as this can cause a false negative result with Macrilen.
  • You will need to fast (go without food) for at least 8 hours before taking Macrilen.

What are the most common side effects with Macrilen?

The most common side effects were changed sense of taste, dizziness, headache, fatigue, nausea, hunger, diarrhea, upper respiratory tract infection, feeling hot, excessive sweating, sore nose and throat, and decreased heart rate.

These are not all of the possible side effects of Macrilen. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

Please see Macrilen Important Safety Information and Full Prescribing Information.

Strongbridge is committed to providing a wide range of services and support for patients and their family members living with Primary Periodic Paralysis. Call 844‑KEVEYIS (538‑3947) for more information on any of the support services listed below.

One-on-one support

  • A dedicated case manager is assigned to every patient
  • Patient access managers are available to work with healthcare providers and patients to overcome common barriers to therapy
  • Patients receive routine calls from a licensed pharmacist, which focus on their progress and treatment goals

Genetic testing

  • Uncovering Periodic Paralysis is a no-cost gene panel testing program for patients who may have PPP as well as their eligible first-degree family members
  • The Periodic Paralysis Panel includes analysis for both hyperkalemic and hypokalemic periodic paralysis, testing for the three most common associated genes: SCN4A, CACNA1S, and KCNJ2
  • Visit www.UncoveringPeriodicParalysis.com to order a genetic test or request a specimen collection kit

Access assistance

  • Access and support for patients with and without insurance
  • Information on a $0 co-pay program and other financial assistance
  • Convenient, free specialty pharmacy services, including 24/7 support and home delivery of prescription

Patient education

  • Patient-friendly information on Primary Periodic Paralysis and its management and treatment

Community connection

  • Links to online patient communities and advocacy organizations

*Eligible patients pay as little as $0 with a maximum annual savings of $10,000. The authorized specialty pharmacy will activate the co-pay card for eligible patients and apply for each prescription until the annual maximum has been reached. This card is not valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state pharmacy assistance program. For additional questions about the co-pay program, including eligibility, call Strongbridge CareConnection at 844-KEVEYIS (538‑3947).


Important Safety Information for KEVEYIS

What is KEVEYIS?

KEVEYIS (pronounced keh-VAY-iss) (dichlorphenamide) is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and other similar diseases.

What should you tell your healthcare provider before taking KEVEYIS?

Tell your doctor if you are allergic to dichlorphenamide or other sulfa drugs; if you take high doses of aspirin, or if you have lung or liver disease; if you are pregnant, plan to become pregnant, or are breastfeeding or plan to breastfeed.

What should you know about KEVEYIS?

  • Severe allergic and other reactions have happened with sulfonamides (drugs such as KEVEYIS) and have sometimes been fatal. Stop taking KEVEYIS at the first sign of skin rash, swelling, difficulty breathing, or any other unexpected side effect or reaction, and call 911 right away.
  • Tell your healthcare provider if you take aspirin or if another healthcare provider instructs you to begin taking aspirin. High doses of aspirin should not be taken with KEVEYIS.
  • KEVEYIS can cause your body to lose potassium, which can lead to heart problems. Your healthcare provider will measure the potassium levels in your blood before you start treatment and at certain times during treatment.
  • Tell your healthcare provider about all other prescription and over-the-counter medicines you take, including supplements, as some medicines can interact with KEVEYIS.
  • While taking KEVEYIS, your body may produce too much acid or may not be able to remove acid from the body. Your healthcare provider may run tests on a regular basis to check for signs of acid buildup.
  • KEVEYIS may increase your risk of falling. Tell your healthcare provider right away if you experience a fall while taking KEVEYIS.
  • The risks of falls and acid buildup are greater in elderly patients.
  • It is not known whether KEVEYIS is safe or effective for people younger than 18 years of age.

What are the most common side effects with KEVEYIS?

The most common side effects are a feeling of numbness, tingling or burning (“pins and needles”) in the toes, feet, hands or fingers; trouble with memory or thinking; feeling confused; and unpleasant taste in the mouth.

These are not all of the possible side effects of KEVEYIS. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

Please see KEVEYIS Important Safety Information and Full Prescribing Information.

© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
Macrilen is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V14 08/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program